Gainers
- Avadel Pharmaceuticals (NASDAQ:AVDL) stock moved upwards by 30.6% to $5.5 during Monday's after-market session. This security traded at a volume of 289.1K shares come close, making up 76.3% of its average volume over the last 100 days. The company's market cap stands at $324.6 million.
- Cabaletta Bio (NASDAQ:CABA) stock rose 6.91% to $1.7. The market value of their outstanding shares is at $49.2 million.
- Cosmos Holdings (NASDAQ:COSM) shares rose 6.59% to $0.97. The market value of their outstanding shares is at $17.0 million. As per the news, the Q4 earnings report came out 4 days ago.
- Checkpoint Therapeutics (NASDAQ:CKPT) stock rose 6.06% to $1.4. The market value of their outstanding shares is at $126.8 million.
- Better Therapeutics (NASDAQ:BTTX) stock rose 5.83% to $1.27. The company's market cap stands at $29.9 million.
- Kintara Therapeutics (NASDAQ:KTRA) stock moved upwards by 5.11% to $0.32. Today's trading volume for this security ended up closing at 341.6K shares, which is 32.7 percent of its average volume over the last 100 days. The company's market cap stands at $20.8 million.
Losers
- Universal Health Services (NYSE:UHS) stock declined by 12.1% to $122.01 during Monday's after-market session. At the close, Universal Health Services's trading volume reached 62.5K shares. This is 9.3% of its average volume over the last 100 days. The company's market cap stands at $9.0 billion. As per the news, the Q1 earnings report came out today.
- Erytech Pharma (NASDAQ:ERYP) stock fell 10.72% to $1.5. This security traded at a volume of 8.5 million shares come close, making up 7661.6% of its average volume over the last 100 days. The company's market cap stands at $46.5 million.
- Bellicum Pharmaceuticals (NASDAQ:BLCM) stock fell 5.15% to $1.66. The market value of their outstanding shares is at $14.1 million.
- BioCardia (NASDAQ:BCDA) stock decreased by 4.71% to $1.62. The company's market cap stands at $27.3 million.
- Avinger (NASDAQ:AVGR) shares declined by 4.68% to $2.65. The market value of their outstanding shares is at $14.3 million.
- Genocea Biosciences (NASDAQ:GNCA) stock declined by 4.44% to $0.36. Genocea Biosciences's trading volume hit 324.6K shares by close, accounting for 21.0% of its average volume over the last 100 days. The company's market cap stands at $20.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
